Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine the effects of three different doses of bardoxolone methyl administered orally
on the kidney function (glomular filtration rate) in patients with diabetic nephropathy.